Helping You Build Wealth With Honest Research
Since 1996. Read On...

MEMBER'S LOGINX

     
Invalid Username / Password
   
     
   
     
 
Invalid Captcha
   
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

PARABOLIC DRUGS vs PANACEA BIOTECH - Comparison Results

Rs 100 invested in...

Loading...
DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    PARABOLIC DRUGS PANACEA BIOTECH PARABOLIC DRUGS/
PANACEA BIOTECH
 
P/E (TTM) x -1.8 -163.3 - View Chart
P/BV x - 3.0 - View Chart
Dividend Yield % 0.0 0.0 -  

Financials

 PARABOLIC DRUGS   PANACEA BIOTECH
EQUITY SHARE DATA
    PARABOLIC DRUGS
Mar-18
PANACEA BIOTECH
Mar-24
PARABOLIC DRUGS/
PANACEA BIOTECH
5-Yr Chart
Click to enlarge
High Rs10202 4.9%   
Low Rs6109 5.5%   
Sales per share (Unadj.) Rs11.891.3 12.9%  
Earnings per share (Unadj.) Rs-9.3-0.2 3,784.2%  
Cash flow per share (Unadj.) Rs-5.85.7 -101.1%  
Dividends per share (Unadj.) Rs00-  
Avg Dividend yield %00-  
Book value per share (Unadj.) Rs-142.4137.5 -103.6%  
Shares outstanding (eoy) m61.8961.25 101.0%   
Bonus / Rights / Conversions 00-  
Price / Sales ratio x0.71.7 39.3%   
Avg P/E ratio x-0.9-632.8 0.1%  
P/CF ratio (eoy) x-1.427.0 -5.0%  
Price / Book Value ratio x-0.11.1 -4.9%  
Dividend payout %00-   
Avg Mkt Cap Rs m4909,523 5.1%   
No. of employees `000NANA-   
Total wages/salary Rs m981,496 6.6%   
Avg. sales/employee Rs Th00-  
Avg. wages/employee Rs Th00-  
Avg. net profit/employee Rs Th00-  
INCOME DATA
Net Sales Rs m7325,592 13.1%  
Other income Rs m42258 16.1%   
Total revenues Rs m7735,850 13.2%   
Gross profit Rs m-291160 -181.9%  
Depreciation Rs m216367 58.8%   
Interest Rs m9336 259.6%   
Profit before tax Rs m-55815 -3,777.1%   
Minority Interest Rs m00-   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m00-   
Tax Rs m1830 59.0%   
Profit after tax Rs m-575-15 3,823.8%  
Gross profit margin %-39.72.9 -1,390.6%  
Effective tax rate %-3.2201.9 -1.6%   
Net profit margin %-78.7-0.3 29,226.7%  
BALANCE SHEET DATA
Current assets Rs m7374,852 15.2%   
Current liabilities Rs m3,9423,088 127.6%   
Net working cap to sales %-438.131.5 -1,389.1%  
Current ratio x0.21.6 11.9%  
Inventory Days Days1185 0.4%  
Debtors Days Days14437 383.7%  
Net fixed assets Rs m3,3309,270 35.9%   
Share capital Rs m61961 1,010.5%   
"Free" reserves Rs m-9,4328,359 -112.8%   
Net worth Rs m-8,8138,420 -104.7%   
Long term debt Rs m8,352210 3,978.5%   
Total assets Rs m4,08914,121 29.0%  
Interest coverage x-5.01.4 -354.0%   
Debt to equity ratio x-0.90 -3,801.1%  
Sales to assets ratio x0.20.4 45.2%   
Return on assets %-11.80.1 -8,025.8%  
Return on equity %6.5-0.2 -3,653.3%  
Return on capital %100.90.6 17,208.0%  
Exports to sales %22.054.9 40.1%   
Imports to sales %2.624.0 10.8%   
Exports (fob) Rs m1613,071 5.2%   
Imports (cif) Rs m191,345 1.4%   
Fx inflow Rs m1613,195 5.0%   
Fx outflow Rs m201,797 1.1%   
Net fx Rs m1411,399 10.1%   
CASH FLOW
From Operations Rs m31-1 -3,067.0%  
From Investments Rs m9102 8.4%  
From Financial Activity Rs m-37-28 131.9%  
Net Cashflow Rs m273 3.1%  

Share Holding

Indian Promoters % 37.1 72.9 50.9%  
Foreign collaborators % 0.7 0.0 -  
Indian inst/Mut Fund % 8.6 1.5 564.7%  
FIIs % 8.1 0.4 2,178.4%  
ADR/GDR % 0.0 0.0 -  
Free float % 62.2 27.1 229.3%  
Shareholders   13,652 39,982 34.1%  
Pledged promoter(s) holding % 0.0 0.0 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare PARABOLIC DRUGS With:   DIVIS LABORATORIES    CIPLA    SUN PHARMA    DR. REDDYS LAB    MANKIND PHARMA    


More on PARABOLIC DRUGS vs Panacea Biotech

No comparison is complete without understanding how the stock prices have performed over a period of time.

Here's a brief comparison:

PARABOLIC DRUGS vs Panacea Biotech Share Price Performance

Period PARABOLIC DRUGS Panacea Biotech S&P BSE HEALTHCARE
1-Day -4.84% -1.28% 1.23%
1-Month 26.11% 31.07% -0.24%
1-Year 141.53% 172.78% 43.62%
3-Year CAGR -11.38% 33.42% 20.35%
5-Year CAGR -6.58% 26.39% 26.24%

* Compound Annual Growth Rate

Here are more details on the PARABOLIC DRUGS share price and the Panacea Biotech share price.

Moving on to shareholding structures...

The promoters of PARABOLIC DRUGS hold a 37.8% stake in the company. In case of Panacea Biotech the stake stands at 72.9%.

To review how promoter stakes have changed over time, and how much of the promoter stake is pledged, please see the shareholding pattern of PARABOLIC DRUGS and the shareholding pattern of Panacea Biotech.

Finally, a word on dividends...

In the most recent financial year, PARABOLIC DRUGS paid a dividend of Rs 0.0 per share. This amounted to a Dividend Payout ratio of -0.0%.

Panacea Biotech paid Rs 0.0, and its dividend payout ratio stood at -0.0%.

You may visit here to review the dividend history of PARABOLIC DRUGS, and the dividend history of Panacea Biotech.

For a sector overview, read our pharmaceuticals sector report.



Today's Market

Sensex Today Rallies 1,961 points | Nifty Above 23,900 | 4 Reasons Why Indian Share Market is Rising Sensex Today Rallies 1,961 points | Nifty Above 23,900 | 4 Reasons Why Indian Share Market is Rising(Closing)

After opening the day higher, Indian benchmark indices remained positive as the session progressed and ended the day on firm footing.